Donating blood to get back to work during COVID-19

Credit: CC0 Public Domain

Dear Mayo Clinic: I saw an article recently about how donating blood could help treat people who have been diagnosed with COVID-19 and maybe let people go back to work. My neighbor said she was going to have a test and then donate blood, but she was not diagnosed with COVID-19, as far as I know. I think I may have had it based on my symptoms, but I never went to the hospital. Can I donate blood to help someone else? Or better yet, will it show that it’s OK for me to go back to work?

Answer: Certainly there is a lot of information about the various tests that are available for COVID-19 and donations. It is important to understand that there are two main types of tests: and serologic tests.

Molecular tests, frequently done with nose swabs, detect the genetic material of the and indicate whether the patient currently has and is infected with the virus. Serology tests, which are likely what your neighbor is referring to, are tests performed on and detect our to the virus by looking for . Antibodies, which are essentially proteins produced by our immune system, are a major component of how we fight off any infectious disease. They will attach to and essentially kill or inactivate the virus.

Importantly, everyone’s is a little bit different, so the time it takes for each person to develop these antibodies and how long they last can vary. So even if you or your neighbor had COVID-19 and didn’t know it, it would take anywhere from a few days to a couple of weeks for this antibody response to develop. And because of this, antibody tests are not used to diagnose infection, but rather are used to determine if a patient has been infected at some point in the past.

Blood donation has been in the news lately for several reasons. First, blood donations are always needed, and it is important to continue to donate blood as we weather the COVID-19 pandemic so that we can ensure we have enough supply to take care of people who might need a transfusion for any reason. Secondly, blood, or more specifically plasma obtained from individuals with antibodies to COVID-19, is being used to treat some patients that are currently infected and hospitalized with COVID-19.

To meet criteria to be a convalescent plasma donor, you would require a prior positive result by a COVID-19 molecular test, be recovered without symptoms and test positive for antibodies to the virus. Preliminary reports indicate that these convalescent plasma transfusions are providing relief to some of the sickest patients, and it is such a generous gift that some of us can provide to those fighting the virus, providing hope to someone else.

I know that a lot of people are eager to get tested to know if they have been infected with COVID-19 and have since recovered—in part because there’s really been a lot of interest at the local, state and national levels to use serologic testing for return-to-work initiatives. Unfortunately, given what we know, I would be cautious against relying solely on a serologic test result to guide return-to-work decisions and recommendations.

We need to exercise caution with how we use the results from these tests. Individuals who positive for antibodies to COVID-19 may be at lower risk for reinfection compared to an antibody-negative individual, but we still really don’t understand or know the level or the duration of protective immunity against reinfection that these antibodies provide us.

One of the biggest questions that we are trying to answer is whether an individual will develop complete or partial immunity to COVID-19 after diagnosis and recovery, and, if so, how long does that last? To be honest, because we’ve really only been dealing with this virus for four or five months, we don’t have a good sense of the level or duration of such protective immunity. From prior studies during the SARS outbreak in the early-2000s, we know that at least some protective immunity against that virus, which is closely related to SARS-CoV-2, seemed to be detectable for about two to three years after infection. But there are some other preliminary animal studies suggesting only short-term immunity.

We really need more studies in this area before we can make any conclusive comments on the duration of antibody protection from reinfection.

Right now, if you are able, please consider regardless of whether or not you meet current criteria to be a COVID-19 convalescent plasma donor.

Follow the latest news on the coronavirus (COVID-19) outbreak

©2020 Mayo Foundation for Medical Education and Research
Distributed by Tribune Content Agency, LLC.

Q&A: Donating blood to get back to work during COVID-19 (2020, May 19)
retrieved 19 May 2020

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.


Related posts:

Germany to lift travel warning for Europe from June 15
Weight, blood pressure higher in younger patients with T2DM
Reducing number of BP meds may be safe in some older adults
At-home gene test for breast, ovarian cancers looks effective
People are avoiding the ER during COVID-19 crisis at their peril: study
In a first, researchers use base editing to correct recessive genetic deafness and restore partial h...
Engineered T cells for type 1 diabetes move closer to clinic
Cardiologist investigates why TAVR might not work for some heart patient
Metaanalyse: Monotherapie der Onychomykose - Biermann Medizin
Belgium to reopen borders with neighbours on June 15
DDG: Ernährungsreport des BMEL ignoriert Ausmaß der Fehlernährung
Cholesterol levels dropping in Western nations—but rising in Asia
Studie: Aussagen zur Ansteckungsgefahr durch Kinder bleiben bestehen
how physicians used it 500 years ago to control the bubonic plague
Uniklinik Ulm bietet nun Fertilitätsbehandlugnen mit Samenspende an
Remote devices for telehealth see surge in demand
Wundheilung detailliert aufgeschlüsselt - Biermann Medizin
Diet, gut microbes affect effectiveness of cancer treatment, research reveals
Forschung abseits von COVID-19: Kommen Krebsmedizin und Co. nun zu kurz?
Helping unlock personalised interventions for kids with developmental disabilities
Diamanttechnik im Herzkatheterlabor - Biermann Medizin
Benzodiazepine use before conception is linked to increased risk of ectopic pregnancy
Verbesserte Wundheilung mit thrombozytenreichem Plasma
Method to identify neural inputs that convey information for defined behaviors
Virchowbund: Die richtigen Lehren aus Corona ziehen
UK mulls 'air bridges' with low-risk countries
3-D-Gebärdensprach-Avatar - Biermann Medizin
A satisfying romantic relationship may improve breast cancer survivors' health
UKE-Studie untersucht Folgen der Corona-Pandemie für die psychische Gesundheit von Kindern
Families and communities are central to the recovery of Sierra Leone's former child soldiers
KMT-Patienten: Sichere Augenversorgung in der Corona-Krise
Expression of certain genes may affect vulnerability to post-traumatic stress disorder
Corona-Pandemie verschlechtert wirtschaftliche Lage der Krankenhäuser
Negative emotions cause stronger appetite responses in emotional eaters
Final states reopen amid worries that protests will spark new COVID infections
Scientists find a switch to flip and turn off breast cancer growth and metastasis
Impact of COVID-19 infection in blood cancer patients
Study in twins finds our sensitivity is partly in our genes
NIH funded research related to every new cancer drug approved from 2010-2016, totals $64B
Social status helped and hindered by the same behaviors and traits worldwide
Concerns mount about two studies on drugs for coronavirus
New CRISPR advance may solve key quandary
Spain records no virus deaths for second day running
Kölner Forschungsprojekt gestartet: COVID-19-Krise aus Sicht des ambulanten Sektors
Understanding the role of cardiorespiratory fitness and body composition in brain health
Neue Nachwuchsgruppe „Zellbiologie der RNA-Viren“ am HPI
Maria shriver and AARP take on Alzheimer's in women
Viel weniger Schlaganfall- und Herzinfarktpatienten in Notaufnahmen
Rolling lockdowns could protect both economies and health in low-income countries
Neue Leitung der Allgemein- und Viszeralchirurgie am Klinikum Kassel
Lab-grown miniature human livers successfully transplanted in rats
Mehr Lebertransplantationen im ersten Quartal
Facts and myths about obesity, emerging as a key factor in COVID-19 hospitalization
Jagd auf lebensbedrohliche Metastasen - Biermann Medizin
Where are kids getting the most 'empty calories'?
Handhygiene: Zunahme von Handekzemen - Biermann Medizin
Tauvid receives approval for tau pathology imaging
COVID-19: Reproduktionszahl genauer geschätzt - Biermann Medizin
You don't smoke, but your home could have thirdhand smoke residue
Evolutionäre Rätsel Säugetierohr - Biermann Medizin
Back to school in masks as Singapore eases virus curbs
Welche Rolle spielen B-Zellen bei kardiovaskulären Erkrankungen?
Pandemic antibiotics surge will cause more deaths: WHO
Studie: Sterberisiko nach Operationen bei Corona-Infizierten erhöht
Lockdowns ease in Florida, Europe with new tourism rules
Reduced humidity linked to increased COVID-19 risk
Glaukomentstehung: Welche Rolle spielt die körpereigene Immunabwehr?
Resistance to immunosurveillance favors cluster cancer metastasis
ADHS: Gleichstromstimulation zeigt klinische Wirkung
Study examines how Americans are coping with COVID-19 stress
Rheumaerkrankungen in der Corona-Situation - Biermann Medizin
Warmer temperatures slow COVID-19 transmission, but not by much
Virus still potent says WHO, after claim by Italian doctor
Engineers design nanoparticles that stimulate the immune system, helping it to attack tumors
Genetic cause of difference in sexual development uncovered
For each day's delay in social distancing, a COVID-19 outbreak lasts days longer
Evidence supports physical distancing, masks, and eye protection to help prevent COVID-19
Study seeks to optimize comfort for patients removed from ventilators at end of life
Europe loosens lockdown as virus tightens grip on Americas
Your brain needs to be ready to remember?
Italy records fewest new virus cases since February
Most Americans still more worried about COVID-19 spread than the economy
Britain takes its biggest step yet out of lockdown
Obesity a major risk factor for COVID-19 hospitalization
Pathogen scientist collaborating on vaccine that could prevent and treat COVID-19
Scientists develop means for detecting early stages of lung problems caused by COVID-19
UTSA software helps patients receive faster post-pandemic care
Almost 6 in 10 Aussies living in aged care are in inadequately staffed facilities
North Korea to reopen schools as virus fears ease
Moscow eases lockdown despite high virus caseload
Hauchdünne Fasern sollen Nerven nach Hirn-OP schützen
Debates rage in Britain as some children go back to school
Mögliches Referenzmessverfahren für die Analyse auf SARS-CoV-2
Putzfimmel im Gehirn - Biermann Medizin
Arbeitsbedingungen in der Intensivpflege prekärer denn je – DGIIN veröffentlicht Stellungnahme
US records 1,225 coronavirus deaths in 24 hours: Johns Hopkins
Coronavirus hopes and fears center on 'immunity'
Assessing cancer diagnosis in children with birth defects
Public health campaigns can do better on cannabis harm reduction
Evolution of pandemic coronavirus outlines path from animals to humans

Leave a Reply

Your email address will not be published. Required fields are marked *

Next Post

Schnellere Identifikation von Krankheitserregern dank neuem Verfahren

Tue May 19 , 2020
In Deutschlands Krankenhäusern zählen Infektionen zu den größten Herausforderungen. Ein Großteil hiervon machen die so genannten Sepsen aus. Laut einer Studie des Universitätsklinikums Jena erkranken bundesweit mehr als 320.000 Menschen – ein Viertel der Betroffenen stirbt an den Folgen. Basierend auf dieser Analyse ist davon auszugehen, dass jährlich nahezu 16.000 […]